| Serial Number | 97486277 |
| Word Mark | TRANSTHERA |
| Filing Date | Friday, July 1, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 26, 2024 |
| Registration Number | 7575186 |
| Registration Date | Tuesday, November 26, 2024 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 24, 2024 |
| Description of Mark | The mark consists of the stylized wording "TransThera" with the stylized letter "n" having an elongated right side and a design with stylized leaves above, a curved line above the middle of the mark, and with four Chinese characters below the stylized wording that transliterate to "Yao Jie An Kang". |
| NOT AVAILABLE | The non-Latin characters in the mark transliterate to Yao Jie An Kang and this means medicine, fast, safe and healthy in English. |
| Goods and Services | Vaccines; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; Medicines for alleviating constipation; Medicines for intestinal disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Translation of Words in Mark | The wording TransThera has no meaning in a foreign language. |
| NOT AVAILABLE | THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "YAO JIE AN KANG" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 21, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | TransThera Sciences (Nanjing), Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Nanjing 210032 CN |
| Party Name | TransThera Sciences (Nanjing), Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Nanjing 210032 CN |
| Party Name | TransThera Sciences (Nanjing), Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Nanjing 210032 CN |
| Event Date | Event Description |
| Thursday, March 2, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 5, 2022 | NEW APPLICATION ENTERED |
| Thursday, July 21, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 22, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Saturday, February 25, 2023 | ASSIGNED TO EXAMINER |
| Thursday, March 2, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, March 2, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 2, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, March 2, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 22, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 11, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, November 22, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, November 22, 2023 | SOU EXTENSION 1 FILED |
| Wednesday, November 22, 2023 | SOU EXTENSION 1 GRANTED |
| Friday, November 24, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, June 5, 2024 | TEAS PETITION TO AMEND BASIS RECEIVED |
| Wednesday, June 5, 2024 | 44(e) PETITION - RECEIVED |
| Thursday, June 6, 2024 | SOU EXTENSION 2 FILED |
| Wednesday, July 10, 2024 | ASSIGNED TO PETITION STAFF |
| Thursday, July 11, 2024 | PETITION INQUIRY LETTER ISSUED |
| Monday, July 22, 2024 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Thursday, August 8, 2024 | PETITION GRANTED - EXTENSION REQUEST FILED |
| Thursday, August 8, 2024 | NOTICE OF REVIVAL - E-MAILED |
| Thursday, August 15, 2024 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
| Thursday, August 15, 2024 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Thursday, August 15, 2024 | ASSIGNED TO PETITION STAFF |
| Thursday, August 15, 2024 | SOU EXTENSION 2 GRANTED |
| Thursday, August 15, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 19, 2024 | NOTICE OF ALLOWANCE CANCELLED |
| Monday, August 19, 2024 | CASE RETURNED TO EXAMINATION |
| Wednesday, September 4, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 24, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 24, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 26, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 26, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, June 6, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 11, 2023 | PUBLISHED FOR OPPOSITION |